Search

 
Start a new search




Results 1-10 of 20.
 |   | 
JRC N°Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)
JRC905452014Combination of Antiretroviral Drugs and Radioimmunotherapy Specifically Kills Infected Cells from HIV-Infected IndividualsTSUKROV D; MCFARREN A; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; DOLCE E; GORNY M.k.; ZOLLA-PAZNER S.; BERMAN J; SCHOENBAUM E; ZINGMAN Bs; CASADEVALL A.; DADACHOVA E.
JRC927112014Polylysine-based Effector Molecules and Clearing Agents for Pretargeting Systems in Therapy and Imaging - Increasing Avidity and Specific Activity and Providing Many Ways to Optimize In Vivo DistributionGUSTAFSSON Anna; BAECK Tom; ALBERTSSON Per; PALM Stig; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; LINDEGREN Sture
JRC933312014α-Radioimmunotherapy with 213Bi-anti-CD38 immunoconjugates is effective in a mouse model of human multiple myelomaTEILUF K; SEIDL C.; BLECHERT B.; GAERTNER F. C.; GILBERTZ K.-P.; FERNANDEZ V; BASSERMANN F; ENDELL J; BOXHAMMER R; LECLAIR Stephane; VALLON M.; AICHLER M; FEUCHTINGER A; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; ESSLER M.
JRC902002014Influence of tumour size on targeted alpha therapy with 213Bi-[DOTA,Tyr3]octreotate (DOTA-TATE) in a small cell lung carcinoma (SCLC) mouse model.CHAN Ho-Sze; KONIJNENBERG M.w.; DE BLOIS Erik; KOELEWIJN S.j.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; BREEMAN Wouter; DE JONG Marion
JRC912732014Alphaknife for glioma tumors: two years experiences with targeted alpha therapy of 213Bi-substance PKROLICKI Leszek; MORGENSTERN Alfred; KUNIKOWSKA Jolanta; KOZIARA H; KROLICKI B; JAKUCINSKI M; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank
JRC737812014Treatment of experimental pancreatic cancer with 213-Bismuth-labeled chimeric antibody to single-strand DNABRYAN R. A.; JIANG Z.; JANDL T; STRAUSS J; KOBA W; ONYEDIKA C; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; EPSTEIN A; DADACHOVA E.
JRC718162014213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experienceKRATOCHWIL Clemens; GIESEL Frederik; BRUCHERTSEIFER Frank; MIER Walter; APOSTOLIDIS Christos; BOLL Rose; MURPHY Karen; HABERKORN Uwe; MORGENSTERN Alfred
JRC886732014Targeted alpha therapy of glioblastoma multiforme: First clinical experience with 213Bi-substance PMORGENSTERN Alfred; KROLICKI Leszek; KUNIKOWSKA Jolanta; KOZIARA H; KROLICKI B; JAKUCINSKI M; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank
JRC886712014Optimizing energy window settings for microSPECT of 213BiDE SWART J; SEGBERS M; CHAN Ho-Sze; MORGENSTERN Alfred; KOELEWIJN S.j.; BRUCHERTSEIFER Frank; DE JONG Marion; BEEKMAN F.j.; KONIJNENBERG M.w.
JRC886722014Step forward with Bi-213: Cyclen-based phosphonates show improved radiolabeling and stabilityŠIMEČEK Jakub; HERMANN Petr; SEIDL C.; MORGENSTERN Alfred; NOTNI Johannes; BRUCHERTSEIFER Frank; WESTER Hans-Jürgen
Results 1-10 of 20.

Discover